차입 증가 → 이자부담 → 수익성 악화
Critical부채가 +54.7% 늘며 이자보상배율이 28.4x에서 16.7x로 하락했다. ROE도 25.7%에서 23.7%로 낮아져 차입 부담이 수익성을 누르고 있다.
Evidence
부채 YoY +54.7%이자보상배율 28.4x→16.7xROE 25.7%→23.7%
MAKUS
093520 · KOSDAQ₩26,200+1.16%
2026-09-04 closeMAKUS last closed at ₩26,200 (+1.16%) on 2026-09-04. Listed on KOSDAQ; price, financials and dividends update daily after market close.
Loading chart…
Close
Super Strong RS 83 · top 17%
New high + volume — the real recordrecord · not a prediction
Last 30 sessions
303 picks
Next-day win rate
50.7%
Avg next-day
-0.11%
vs market
-0.49%p
Every new-high-plus-volume pick we actually published (Korea market) — not this stock alone.
Signal history
| Date | Signal | +20 trading days |
|---|---|---|
A record, not a prediction.
How this is calculated
"·" means fewer than 20 trading days have passed since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.
Trade plan
Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.
A calculator · not advice or a guarantee
Financials & valuation at a glance
B+
Overall: 반도체 48/125 · top 38%
Factor composite · relative position in sector
PER 18.51 · PBR 3.28 — own-history percentile 16/100 · 1/100
Open self-history band
PER16/100
PBR1/100
Factual information · not investment advice
Past reported results · not investment advice
More — deeper indicators
Annual dividend
Split-adjusted annual DPS history and available grade axes
Paid 10 consecutive years · Raised 2 consecutive years · Yield 0.76% (based on 2025 payment of 200원) · 3-year growth +18.6%
Per-share amount adjusted for splits and capital reductions · Factual information, not investment advice.
Financial safety
Reference indicatorAs of 2024Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 3.57
Distress
Grey
Safe
- Altman Z''
- 3.57
- Beneish M-Score
- -1.82
- Sloan accrual
- -7.17%
No statistical flag
부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.
Factual information, not investment advice.
Why has this company moved this way?
Auditable observations with the original numeric evidence.
Factual information, not investment advice.
Earnings quality · Piotroski F-Score
3/9Weak
Piotroski measures year-over-year financial improvement, not absolute quality.
Financial improvement score3/9
Profitability
- Positive ROAPass
- Positive OCFPass
- Improving ΔROANot passed
- Accruals (OCF > net income)Pass
Leverage & liquidity
- Lower debtNot passed
- Higher current ratioNot passed
- No new sharesNot passed
Efficiency
- Higher gross marginNot passed
- Higher asset turnoverNot passed
Calculation note: F7(신주)은 equity/asset 유지로 근사
Already-stable companies may score lower when year-over-year improvement is limited.
Factual information, not investment advice.
Industry structure
KRAs of 2026-09-05반도체
This stock is in 반도체: revenue rank 53 of 125, share 0.1%.
53 / 1250.1%revenue share
Who dominates this industry?
- 1삼성전자75.4%
- 2SK하이닉스16.6%
- 3SK스퀘어0.5%
- 4동진쎄미켐0.4%
- 5하나마이크론0.3%
- 6매커스0.1%
Concentration
ConcentratedCR3 92.5%HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.
Polarization
Winner-take-all deepeningConsistentPolarization measures industry gaps and structure, not valuation, forecast, or investment advice.
Margin lens
- IQR%p
- 16.34
- Direction
- 확대
- Level
- 넓음
- Years
- 6
Value lens
- P90/P10
- 10.1
- Median P/B
- 1.85
- Level
- 넓음
- n
- 123
Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)
Factual information, not investment advice.
Risk sensitivity — adverse assumptions
Metric changes under stated assumptions; not a forecast or investment advice.
Base metrics
- Operating margin
- 13.5%
- Interest coverage
- 16.7x
- Return on equity (ROE)
- 17.7%
Operating margin −5pp
TolerableInterest coverageBase 16.7x adverse case 10.5x
Return on equity (ROE)Base 17.7% adverse case 13.5%
Revenue −15%
TolerableInterest coverageBase 16.7x adverse case 14.2x
Return on equity (ROE)Base 17.7% adverse case 18.8%
Interest rate +2pp
TolerableInterest coverageBase 16.7x adverse case 3.6x
Return on equity (ROE)Base 17.7% adverse case 17.1%
Interest coverage limit
Current margin 12.7ppInterest coverage limit at an operating margin of 0.8%
Interest expense coverage threshold
Key suppliers · Annual report
Annual reportDART · 2026-03-18Suppliers disclosed by the company in its 2026-03-18 annual report.
Suppliers without disclosed amount
FPGA
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.
5%+ major-holding disclosures
- MiriCapitalManagementLLC11.63%2026-08-14 · 증감 +1.73%p
- 피델리티매니지먼트앤리서치컴퍼니엘엘씨10.78%2026-06-09 · 증감 +1.69%p
Other stocks held by the same investors
A filing-based shared-holder record, not investment advice.
- 유수홀딩스KRA000700 →
Shared holders: MiriCapitalManagementLLC
- 대원제약KRA003220 →
Shared holders: 피델리티매니지먼트앤리서치컴퍼니엘엘씨
- 미창석유KRA003650 →
Shared holders: 피델리티매니지먼트앤리서치컴퍼니엘엘씨
- 광동제약KRA009290 →
Shared holders: 피델리티매니지먼트앤리서치컴퍼니엘엘씨
- 영원무역홀딩스KRA009970 →
Shared holders: 피델리티매니지먼트앤리서치컴퍼니엘엘씨
- 에스원KRA012750 →
Shared holders: 피델리티매니지먼트앤리서치컴퍼니엘엘씨
- 하이록코리아KRA013030 →
Shared holders: 피델리티매니지먼트앤리서치컴퍼니엘엘씨
- 환인제약KRA016580 →
Shared holders: 피델리티매니지먼트앤리서치컴퍼니엘엘씨
Connections
AI-extracted related companies · for reference
Customers
Competitors
Same theme
반도체 유통
Recent filings
MAKUS's latest filings on Korea's DART. Open a headline for a reference summary and the original.
Source: DART (Korea electronic disclosure)
About MAKUS
- What technical signals does MAKUS (093520) have?
- MAKUS current technical signals: no active technical signal.
- Is MAKUS a cup-and-handle pattern?
- No. MAKUS has no valid cup-and-handle signal right now.
- What are MAKUS's financials and valuation?
- MAKUS's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Quantus Signal · live data · not investment advice · Privacy Policy